Evidence map›Paper›PMID 7799970›Full record

ArticleMolecular and cellular biology1995

Isoform-specific complementation of the yeast sac6 null mutation by human fimbrin.

A E Adams, W Shen, C S Lin, J Leavitt, P Matsudaira

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Genomic Study ofFrontiers in immunology · 2020
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cell-cycle regulation of formin-mediated actin cable assembly.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

A E AdamsDepartment of Molecular and Cellular Biology, University of Arizona, Tucson 85721.
W Shen
C S Lin
J Leavitt
P Matsudaira
University of Arizona · USWhitehead Institute for Biomedical Research · US

Funding

THE PATHOBIOLOGY OF COLORECTAL CANCERP01CA044704 · NCI · NEW ENGLAND DEACONESS HOSPITAL · PI KOLODNER, RICHARD D · 1987 to 1998
–
ROLE OF METASCHEMATIN PROTEINS IN NEOPLASIAR01CA049423 · NCI · PALO ALTO MEDICAL FOUNDATION RES INST · PI LIN, CHINGSHWUN · 1989 to 1991
–
MOLECULAR ANALYSIS OF THE YEAST ACTIN CYTOSKELETONR01GM045288 · NIGMS · UNIVERSITY OF ARIZONA · PI ADAMS, ALISON E · 1991 to 1999
–
NCI NIH HHS CA44704NCI NIH HHS CA49423NIGMS NIH HHS GM45288
6 · The paper itself

Abstract

The actin cytoskeleton is a fundamental component of eukaryotic cells, with both structural and motile roles. Actin and many of the actin-binding proteins found in different cell types are highly conserved, showing considerable similarity in both primary structure and biochemical properties. To make detailed comparisons between homologous proteins, it is necessary to know whether the various proteins are functionally, as well as structurally, conserved. Fimbrin is an example of a cytoskeletal component that, as shown by sequence determinations and biochemical characterizations, is conserved between organisms as diverse as Saccharomyces cerevisiae and humans. In this study, we examined whether the human homolog can substitute for the yeast protein in vivo. We report here that two isoforms of human fimbrin, also referred to as T- and L-plastin, can both substitute in vivo for yeast fimbrin, also known as Sac6p, whereas a third isoform, I-fimbrin (or I-plastin), cannot. We demonstrate that the human T- and L-fimbrins, in addition to complementing the temperature-sensitive growth defect of the sac6 null mutant, restore both normal cytoskeletal organization and cell shape to the mutant cells. In addition, we show that human T- and L-fimbrins can complement a sporulation defect caused by the sac6 null mutation. These findings indicate that there is a high degree of functional conservation in the cytoskeleton, even between organisms as diverse as S. cerevisiae and humans.

Indexed as

Microfilament ProteinsAnimalsBase SequenceCell SizeChickensCytoskeletonDNA PrimersGenes, FungalGenetic Complementation TestHumansMembrane GlycoproteinsMolecular Sequence DataSaccharomyces cerevisiaeSpores, FungalDNA PrimersMembrane GlycoproteinsMicrofilament Proteinsplastin

Identifiers

PMID7799970
PMCPMC231909
OpenAlexW2138760647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.